Reports from China found a significantly lower rate of ATXN2 intermediate alleles (1.6, 1.5 and 1.9%) among ALS patients as studies involving patients of European origin [49–51]. This evidence concerns the gene ATXN2 and amyotrophic lateral sclerosis.